Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Nov 7, 2011 · 10-Q · 38 days after period end · 0001193125-11-299888
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Net Income | -$4.20M | -$1.67M |
| EPS Diluted | -$0.02 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 7, 2011 · 38 d after period end
